HEK293 Cell Transfection Reagent is a unique formulation based on polycationic liposomes of non-animal origin. It is suitable for large-scale transient transfection of HEK293 cells to produce recombinant proteins, monoclonal antibodies, virus particles (AAV, adenovirus, lentivirus), and virus-like particles.
The global HEK293 Cell Transfection Reagent market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
Increasing demand for HEK293 cell line research, development of biomedical research technologies, clinical application of gene expression, cell analysis, and drug screening, and continuous regulation across the biopharmaceutical industry are the key factors driving the growth of HEK293 cell transfection reagents market revenue.
This report aims to provide a comprehensive presentation of the global market for HEK293 Cell Transfection Reagent, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding HEK293 Cell Transfection Reagent.
Report Scope
The HEK293 Cell Transfection Reagent market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global HEK293 Cell Transfection Reagent market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the HEK293 Cell Transfection Reagent manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
麻豆原创 Segmentation
By Company
Sigma Aldrich
Thermo Fisher Scientific
Merck
Altogen Biosystems
SPEED Biosystems
Mirus Bio
OriGene
Bio-protocol
Novagen
Biontex
HAL
GeneDireX
BOC Sciences
Agilent
Beijing T and L Biotechnology
Sino Biological
Shanghai Biyuntian Biotechnology
Segment by Type
1 ml
10 ml
100 ml
Segment by Application
Gene Expression
Cell Analysis
Protein And Virus Production
Drug Screening
Others
Consumption by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of HEK293 Cell Transfection Reagent manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of HEK293 Cell Transfection Reagent in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.
1 HEK293 Cell Transfection Reagent 麻豆原创 Overview
1.1 Product Overview and Scope of HEK293 Cell Transfection Reagent
1.2 HEK293 Cell Transfection Reagent Segment by Type
1.2.1 Global HEK293 Cell Transfection Reagent 麻豆原创 Value Comparison by Type (2024-2030)
1.2.2 1 ml
1.2.3 10 ml
1.2.4 100 ml
1.3 HEK293 Cell Transfection Reagent Segment by Application
1.3.1 Global HEK293 Cell Transfection Reagent 麻豆原创 Value by Application: (2024-2030)
1.3.2 Gene Expression
1.3.3 Cell Analysis
1.3.4 Protein And Virus Production
1.3.5 Drug Screening
1.3.6 Others
1.4 Global HEK293 Cell Transfection Reagent 麻豆原创 Size Estimates and Forecasts
1.4.1 Global HEK293 Cell Transfection Reagent Revenue 2019-2030
1.4.2 Global HEK293 Cell Transfection Reagent Sales 2019-2030
1.4.3 Global HEK293 Cell Transfection Reagent 麻豆原创 Average Price (2019-2030)
1.5 Assumptions and Limitations
2 HEK293 Cell Transfection Reagent 麻豆原创 Competition by Manufacturers
2.1 Global HEK293 Cell Transfection Reagent Sales 麻豆原创 Share by Manufacturers (2019-2024)
2.2 Global HEK293 Cell Transfection Reagent Revenue 麻豆原创 Share by Manufacturers (2019-2024)
2.3 Global HEK293 Cell Transfection Reagent Average Price by Manufacturers (2019-2024)
2.4 Global HEK293 Cell Transfection Reagent Industry Ranking 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of HEK293 Cell Transfection Reagent, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of HEK293 Cell Transfection Reagent, Product Type & Application
2.7 HEK293 Cell Transfection Reagent 麻豆原创 Competitive Situation and Trends
2.7.1 HEK293 Cell Transfection Reagent 麻豆原创 Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest HEK293 Cell Transfection Reagent Players 麻豆原创 Share by Revenue
2.7.3 Global HEK293 Cell Transfection Reagent 麻豆原创 Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 HEK293 Cell Transfection Reagent Retrospective 麻豆原创 Scenario by Region
3.1 Global HEK293 Cell Transfection Reagent 麻豆原创 Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global HEK293 Cell Transfection Reagent Global HEK293 Cell Transfection Reagent Sales by Region: 2019-2030
3.2.1 Global HEK293 Cell Transfection Reagent Sales by Region: 2019-2024
3.2.2 Global HEK293 Cell Transfection Reagent Sales by Region: 2025-2030
3.3 Global HEK293 Cell Transfection Reagent Global HEK293 Cell Transfection Reagent Revenue by Region: 2019-2030
3.3.1 Global HEK293 Cell Transfection Reagent Revenue by Region: 2019-2024
3.3.2 Global HEK293 Cell Transfection Reagent Revenue by Region: 2025-2030
3.4 North America HEK293 Cell Transfection Reagent 麻豆原创 Facts & Figures by Country
3.4.1 North America HEK293 Cell Transfection Reagent 麻豆原创 Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America HEK293 Cell Transfection Reagent Sales by Country (2019-2030)
3.4.3 North America HEK293 Cell Transfection Reagent Revenue by Country (2019-2030)
3.4.4 United States
3.4.5 Canada
3.5 Europe HEK293 Cell Transfection Reagent 麻豆原创 Facts & Figures by Country
3.5.1 Europe HEK293 Cell Transfection Reagent 麻豆原创 Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe HEK293 Cell Transfection Reagent Sales by Country (2019-2030)
3.5.3 Europe HEK293 Cell Transfection Reagent Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific HEK293 Cell Transfection Reagent 麻豆原创 Facts & Figures by Country
3.6.1 Asia Pacific HEK293 Cell Transfection Reagent 麻豆原创 Size by Country: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific HEK293 Cell Transfection Reagent Sales by Country (2019-2030)
3.6.3 Asia Pacific HEK293 Cell Transfection Reagent Revenue by Country (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America HEK293 Cell Transfection Reagent 麻豆原创 Facts & Figures by Country
3.7.1 Latin America HEK293 Cell Transfection Reagent 麻豆原创 Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America HEK293 Cell Transfection Reagent Sales by Country (2019-2030)
3.7.3 Latin America HEK293 Cell Transfection Reagent Revenue by Country (2019-2030)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa HEK293 Cell Transfection Reagent 麻豆原创 Facts & Figures by Country
3.8.1 Middle East and Africa HEK293 Cell Transfection Reagent 麻豆原创 Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa HEK293 Cell Transfection Reagent Sales by Country (2019-2030)
3.8.3 Middle East and Africa HEK293 Cell Transfection Reagent Revenue by Country (2019-2030)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global HEK293 Cell Transfection Reagent Sales by Type (2019-2030)
4.1.1 Global HEK293 Cell Transfection Reagent Sales by Type (2019-2024)
4.1.2 Global HEK293 Cell Transfection Reagent Sales by Type (2025-2030)
4.1.3 Global HEK293 Cell Transfection Reagent Sales 麻豆原创 Share by Type (2019-2030)
4.2 Global HEK293 Cell Transfection Reagent Revenue by Type (2019-2030)
4.2.1 Global HEK293 Cell Transfection Reagent Revenue by Type (2019-2024)
4.2.2 Global HEK293 Cell Transfection Reagent Revenue by Type (2025-2030)
4.2.3 Global HEK293 Cell Transfection Reagent Revenue 麻豆原创 Share by Type (2019-2030)
4.3 Global HEK293 Cell Transfection Reagent Price by Type (2019-2030)
5 Segment by Application
5.1 Global HEK293 Cell Transfection Reagent Sales by Application (2019-2030)
5.1.1 Global HEK293 Cell Transfection Reagent Sales by Application (2019-2024)
5.1.2 Global HEK293 Cell Transfection Reagent Sales by Application (2025-2030)
5.1.3 Global HEK293 Cell Transfection Reagent Sales 麻豆原创 Share by Application (2019-2030)
5.2 Global HEK293 Cell Transfection Reagent Revenue by Application (2019-2030)
5.2.1 Global HEK293 Cell Transfection Reagent Revenue by Application (2019-2024)
5.2.2 Global HEK293 Cell Transfection Reagent Revenue by Application (2025-2030)
5.2.3 Global HEK293 Cell Transfection Reagent Revenue 麻豆原创 Share by Application (2019-2030)
5.3 Global HEK293 Cell Transfection Reagent Price by Application (2019-2030)
6 Key Companies Profiled
6.1 Sigma Aldrich
6.1.1 Sigma Aldrich Corporation Information
6.1.2 Sigma Aldrich Description and Business Overview
6.1.3 Sigma Aldrich HEK293 Cell Transfection Reagent Sales, Revenue and Gross Margin (2019-2024)
6.1.4 Sigma Aldrich HEK293 Cell Transfection Reagent Product Portfolio
6.1.5 Sigma Aldrich Recent Developments/Updates
6.2 Thermo Fisher Scientific
6.2.1 Thermo Fisher Scientific Corporation Information
6.2.2 Thermo Fisher Scientific Description and Business Overview
6.2.3 Thermo Fisher Scientific HEK293 Cell Transfection Reagent Sales, Revenue and Gross Margin (2019-2024)
6.2.4 Thermo Fisher Scientific HEK293 Cell Transfection Reagent Product Portfolio
6.2.5 Thermo Fisher Scientific Recent Developments/Updates
6.3 Merck
6.3.1 Merck Corporation Information
6.3.2 Merck Description and Business Overview
6.3.3 Merck HEK293 Cell Transfection Reagent Sales, Revenue and Gross Margin (2019-2024)
6.3.4 Merck HEK293 Cell Transfection Reagent Product Portfolio
6.3.5 Merck Recent Developments/Updates
6.4 Altogen Biosystems
6.4.1 Altogen Biosystems Corporation Information
6.4.2 Altogen Biosystems Description and Business Overview
6.4.3 Altogen Biosystems HEK293 Cell Transfection Reagent Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Altogen Biosystems HEK293 Cell Transfection Reagent Product Portfolio
6.4.5 Altogen Biosystems Recent Developments/Updates
6.5 SPEED Biosystems
6.5.1 SPEED Biosystems Corporation Information
6.5.2 SPEED Biosystems Description and Business Overview
6.5.3 SPEED Biosystems HEK293 Cell Transfection Reagent Sales, Revenue and Gross Margin (2019-2024)
6.5.4 SPEED Biosystems HEK293 Cell Transfection Reagent Product Portfolio
6.5.5 SPEED Biosystems Recent Developments/Updates
6.6 Mirus Bio
6.6.1 Mirus Bio Corporation Information
6.6.2 Mirus Bio Description and Business Overview
6.6.3 Mirus Bio HEK293 Cell Transfection Reagent Sales, Revenue and Gross Margin (2019-2024)
6.6.4 Mirus Bio HEK293 Cell Transfection Reagent Product Portfolio
6.6.5 Mirus Bio Recent Developments/Updates
6.7 OriGene
6.6.1 OriGene Corporation Information
6.6.2 OriGene Description and Business Overview
6.6.3 OriGene HEK293 Cell Transfection Reagent Sales, Revenue and Gross Margin (2019-2024)
6.4.4 OriGene HEK293 Cell Transfection Reagent Product Portfolio
6.7.5 OriGene Recent Developments/Updates
6.8 Bio-protocol
6.8.1 Bio-protocol Corporation Information
6.8.2 Bio-protocol Description and Business Overview
6.8.3 Bio-protocol HEK293 Cell Transfection Reagent Sales, Revenue and Gross Margin (2019-2024)
6.8.4 Bio-protocol HEK293 Cell Transfection Reagent Product Portfolio
6.8.5 Bio-protocol Recent Developments/Updates
6.9 Novagen
6.9.1 Novagen Corporation Information
6.9.2 Novagen Description and Business Overview
6.9.3 Novagen HEK293 Cell Transfection Reagent Sales, Revenue and Gross Margin (2019-2024)
6.9.4 Novagen HEK293 Cell Transfection Reagent Product Portfolio
6.9.5 Novagen Recent Developments/Updates
6.10 Biontex
6.10.1 Biontex Corporation Information
6.10.2 Biontex Description and Business Overview
6.10.3 Biontex HEK293 Cell Transfection Reagent Sales, Revenue and Gross Margin (2019-2024)
6.10.4 Biontex HEK293 Cell Transfection Reagent Product Portfolio
6.10.5 Biontex Recent Developments/Updates
6.11 HAL
6.11.1 HAL Corporation Information
6.11.2 HAL HEK293 Cell Transfection Reagent Description and Business Overview
6.11.3 HAL HEK293 Cell Transfection Reagent Sales, Revenue and Gross Margin (2019-2024)
6.11.4 HAL HEK293 Cell Transfection Reagent Product Portfolio
6.11.5 HAL Recent Developments/Updates
6.12 GeneDireX
6.12.1 GeneDireX Corporation Information
6.12.2 GeneDireX HEK293 Cell Transfection Reagent Description and Business Overview
6.12.3 GeneDireX HEK293 Cell Transfection Reagent Sales, Revenue and Gross Margin (2019-2024)
6.12.4 GeneDireX HEK293 Cell Transfection Reagent Product Portfolio
6.12.5 GeneDireX Recent Developments/Updates
6.13 BOC Sciences
6.13.1 BOC Sciences Corporation Information
6.13.2 BOC Sciences HEK293 Cell Transfection Reagent Description and Business Overview
6.13.3 BOC Sciences HEK293 Cell Transfection Reagent Sales, Revenue and Gross Margin (2019-2024)
6.13.4 BOC Sciences HEK293 Cell Transfection Reagent Product Portfolio
6.13.5 BOC Sciences Recent Developments/Updates
6.14 Agilent
6.14.1 Agilent Corporation Information
6.14.2 Agilent HEK293 Cell Transfection Reagent Description and Business Overview
6.14.3 Agilent HEK293 Cell Transfection Reagent Sales, Revenue and Gross Margin (2019-2024)
6.14.4 Agilent HEK293 Cell Transfection Reagent Product Portfolio
6.14.5 Agilent Recent Developments/Updates
6.15 Beijing T and L Biotechnology
6.15.1 Beijing T and L Biotechnology Corporation Information
6.15.2 Beijing T and L Biotechnology HEK293 Cell Transfection Reagent Description and Business Overview
6.15.3 Beijing T and L Biotechnology HEK293 Cell Transfection Reagent Sales, Revenue and Gross Margin (2019-2024)
6.15.4 Beijing T and L Biotechnology HEK293 Cell Transfection Reagent Product Portfolio
6.15.5 Beijing T and L Biotechnology Recent Developments/Updates
6.16 Sino Biological
6.16.1 Sino Biological Corporation Information
6.16.2 Sino Biological HEK293 Cell Transfection Reagent Description and Business Overview
6.16.3 Sino Biological HEK293 Cell Transfection Reagent Sales, Revenue and Gross Margin (2019-2024)
6.16.4 Sino Biological HEK293 Cell Transfection Reagent Product Portfolio
6.16.5 Sino Biological Recent Developments/Updates
6.17 Shanghai Biyuntian Biotechnology
6.17.1 Shanghai Biyuntian Biotechnology Corporation Information
6.17.2 Shanghai Biyuntian Biotechnology HEK293 Cell Transfection Reagent Description and Business Overview
6.17.3 Shanghai Biyuntian Biotechnology HEK293 Cell Transfection Reagent Sales, Revenue and Gross Margin (2019-2024)
6.17.4 Shanghai Biyuntian Biotechnology HEK293 Cell Transfection Reagent Product Portfolio
6.17.5 Shanghai Biyuntian Biotechnology Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 HEK293 Cell Transfection Reagent Industry Chain Analysis
7.2 HEK293 Cell Transfection Reagent Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 HEK293 Cell Transfection Reagent Production Mode & Process
7.4 HEK293 Cell Transfection Reagent Sales and 麻豆原创ing
7.4.1 HEK293 Cell Transfection Reagent Sales Channels
7.4.2 HEK293 Cell Transfection Reagent Distributors
7.5 HEK293 Cell Transfection Reagent Customers
8 HEK293 Cell Transfection Reagent 麻豆原创 Dynamics
8.1 HEK293 Cell Transfection Reagent Industry Trends
8.2 HEK293 Cell Transfection Reagent 麻豆原创 Drivers
8.3 HEK293 Cell Transfection Reagent 麻豆原创 Challenges
8.4 HEK293 Cell Transfection Reagent 麻豆原创 Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 麻豆原创 Size Estimation
10.1.3 麻豆原创 Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
Sigma Aldrich
Thermo Fisher Scientific
Merck
Altogen Biosystems
SPEED Biosystems
Mirus Bio
OriGene
Bio-protocol
Novagen
Biontex
HAL
GeneDireX
BOC Sciences
Agilent
Beijing T and L Biotechnology
Sino Biological
Shanghai Biyuntian Biotechnology
听
听
*If Applicable.
